| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |